2m 2m 2m 2m 2m 2m 2m
VOLITIONRX (VNRX)
NYSE
$2.23+$0.15 (+6.97%)
Price as of Jun 03, 2026 7:58 PM EDT- $22.2MMarket Cap
- -81.77%1-Year Change
- Medical DevicesIndustry
VOLITIONRX (VNRX)
$2.23+$0.15 (+6.97%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.7M +40.04% | 1.2M +59.10% | 775,302 +153.04% | 306,392 +240.30% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.7M +40.04% | 1.2M +59.10% | 775,302 +153.04% | 306,392 +240.30% | |
Sales and Marketing Expense | 3.9M -26.91% | 5.4M -21.61% | 6.8M +4.06% | 6.6M +59.24% | |
Research and Development Expense | -10.1M -30.02% | -14.4M -26.32% | -19.6M +34.17% | -14.6M -6.24% | |
Depreciation and Amortization Expense | 983,706 -11.63% | 1.1M -3.41% | 1.2M +23.12% | 936,084 -0.98% | |
Total Operating Expenses | 23.5M -16.96% | 28.3M -23.13% | 36.8M +14.57% | 32.1M +12.89% | |
Operating Profit | -21.7M -19.56% | -27.0M -24.90% | -36.0M +13.24% | -31.8M +12.17% | |
Interest Income | 600 -93.97% | 9,947 -89.34% | 93,324 -25.50% | 125,265 +4,481.75% | |
Interest Expense | -532,192 +56.36% | -340,362 +53.58% | -221,622 +28.04% | -173,087 +11.09% | |
Interest Income and Expense and Net | -531,592 +60.89% | -330,415 +157.54% | -128,298 +168.28% | -47,822 -68.76% | |
Total Nonoperating Income and Expense | -1.8M +657.36% | -233,015 -175.02% | 310,621 -73.71% | 1.2M -12.04% | |
Income before Taxes | 146,302 +100.54% | -27.0M -25.06% | -36.0M -11,016.08% | 329,676 +88.26% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -23.4M -14.31% | -27.3M -23.60% | -35.7M +16.60% | -30.6M -122.33% | |
Net Income from Continuing Operations Applicable to Common | -23.4M -13.39% | -27.0M -24.41% | -35.7M +16.60% | -30.6M +14.11% | |
Basic EPS and Net Income | -0.22 N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.22 -29.03% | -0.31 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 106.8M +23.46% | 86.5M +21.47% | 71.2M +28.70% | 55.4M +5.12% | |
Diluted Weighted Average Shares | 106.8M +23.46% | 86.5M N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.1M -65.78% | 3.3M -84.25% | 20.7M +90.76% | 10.9M -47.20% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.1M -65.78% | 3.3M -84.25% | 20.7M +90.76% | 10.9M -47.20% | |
Total Current Assets | 2.1M -49.20% | 4.1M -81.44% | 21.9M +79.54% | 12.2M -44.62% | |
Accumulated Depreciation | 6.4M +28.53% | 5.0M +18.75% | 4.2M +26.45% | 3.3M +26.36% | |
Property and Plant and Equipment and Net | 4.0M -9.06% | 4.4M -19.81% | 5.5M +2.41% | 5.4M +9.81% | |
Total Long-Term Assets | 4.0M -9.06% | 4.4M -19.81% | 5.5M +2.41% | 5.4M +9.81% | |
Total Assets | 6.9M -26.58% | 9.4M -66.37% | 28.0M +52.78% | 18.3M -33.45% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 3.3M +284.65% | 860,223 -28.73% | 1.2M +13.15% | 1.1M +33.70% | |
Total Current Liabilities | 12.2M +56.99% | 7.8M -75.53% | 31.8M +83.12% | 17.4M +166.83% | |
Total Long-Term Debt | 7.3M +83.58% | 4.0M +9.05% | 3.6M +30.43% | 2.8M +22.39% | |
Total Long-Term Liabilities | 28.0M +542.45% | 4.4M +9.01% | 4.0M +25.90% | 3.2M +30.20% | |
Total Liabilities | 42.5M +19.68% | 35.5M -3.15% | 36.7M +71.15% | 21.4M +119.30% | |
Retained Earnings | -252.9M +10.18% | -229.5M +13.31% | -202.6M +21.12% | -167.3M +22.10% | |
Total Stockholders Equity | -34.2M +37.49% | -24.9M +219.24% | -7.8M +149.52% | -3.1M -117.64% | |
Total Shares Outstanding | 125.8M +30.89% | 96.1M +17.34% | 81.9M +41.51% | 57.9M +7.63% | |
Cash Flow | |||||
Cash from Operating Activities | -19.7M -23.98% | -25.9M +43.35% | -18.1M +18.23% | -15.3M -26.74% | |
Capital Expenditures | 89,558 -67.73% | 277,499 -74.39% | 1.1M -30.98% | 1.6M +61.28% | |
Cash from Investing Activities | -89,558 -84.39% | -573,852 -47.05% | -1.1M -30.98% | -1.6M +61.28% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.1M +97.44% | 8.7M -70.13% | 29.0M +317.74% | 6.9M -69.65% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,258.47% -42.56% | -2,190.90% -52.80% | -4,641.76% -55.25% | -10,372.36% -67.04% | |
Return on Assets | -286.58% +96.34% | -145.96% -5.40% | -154.29% +15.44% | -133.66% -126.17% | |
Return on Equity | 78.97% -52.62% | 166.67% -74.47% | 652.88% +255.71% | -419.30% -152.05% | |
Revenue Growth | 40.04% -32.25% | 59.10% -61.38% | 153.04% -36.31% | 240.30% -57.86% | |
Current Ratio | 0.17 -67.64% | 0.52 -24.14% | 0.69 -1.96% | 0.70 -79.24% | |
Cash Ratio | 0.09 -78.21% | 0.42 -35.65% | 0.65 +4.18% | 0.63 -80.21% | |
Debt-to-Equity Ratio | -0.31 +59.68% | -0.19 -68.80% | -0.62 -49.65% | -1.23 -810.10% | |
Debt-to-Assets Ratio | 1.53 +198.97% | 0.51 +196.18% | 0.17 -17.75% | 0.21 +88.35% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow